In other words, the price has increased by $0.00 from its previous closing price. On the day, 956044 shares were traded.
Ratios:
For a deeper understanding of Avid Bioservices Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 1.06.
On March 14, 2023, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 12 ’24 when Kwietniak Matthew R. sold 274 shares for $6.77 per share. The transaction valued at 1,855 led to the insider holds 19,829 shares of the business.
Hart Daniel R sold 2,408 shares of CDMO for $14,857 on Jan 10 ’24. The Chief Financial Officer now owns 79,305 shares after completing the transaction at $6.17 per share. On Jan 10 ’24, another insider, Ziebell Mark R, who serves as the V. P., General Counsel of the company, sold 1,346 shares for $6.17 each. As a result, the insider received 8,305 and left with 63,269 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDMO now has a Market Capitalization of 402.20M and an Enterprise Value of 566.07M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.93 while its Price-to-Book (P/B) ratio in mrq is 2.18. Its current Enterprise Value per Revenue stands at 4.02 whereas that against EBITDA is 937.20.
Stock Price History:
Over the past 52 weeks, CDMO has reached a high of $21.05, while it has fallen to a 52-week low of $4.07. The 50-Day Moving Average of the stock is 7.01, while the 200-Day Moving Average is calculated to be 8.63.
Shares Statistics:
For the past three months, CDMO has traded an average of 1.36M shares per day and 976.01k over the past ten days. A total of 62.69M shares are outstanding, with a floating share count of 62.58M. Insiders hold about 1.05% of the company’s shares, while institutions hold 90.99% stake in the company. Shares short for CDMO as of Mar 15, 2024 were 10.84M with a Short Ratio of 8.00, compared to 5.65M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 17.14% and a Short% of Float of 20.47%.
Earnings Estimates
There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.05 for the current quarter, with a high estimate of -$0.03 and a low estimate of -$0.07, while EPS last year was $0.01. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.02 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.24 and -$0.3 for the fiscal current year, implying an average EPS of -$0.27. EPS for the following year is -$0.06, with 4 analysts recommending between $0.03 and -$0.18.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for CDMO’s current fiscal year. The highest revenue estimate was $140.13M, while the lowest revenue estimate was $137M, resulting in an average revenue estimate of $138.66M. In the same quarter a year ago, actual revenue was $149.27M, down -7.10% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $165.53M in the next fiscal year. The high estimate is $175M and the low estimate is $156.99M. The average revenue growth estimate for next year is up 19.40% from the average revenue estimate for this year.
